BioSpace News Archive

Business

Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023

Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will present 30 abstracts during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

May 17, 2023
·
34 min read
BioForest

Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy

Cadence Neuroscience announced today that it has secured $26 million in Series B financing.

May 17, 2023
·
3 min read
Business

Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia™

Distribution Agreement Grants Pentec Exclusive Distribution Rights for Altemia Lobe’s Novel Sickle Cell Anemia Medical Food.

May 17, 2023
·
7 min read
Drug Development

Siren Biotechnology Unveils Preclinical Data for Universal AAV Immuno-Gene Therapy™ for Cancer, a Novel Modality that Combines AAV Gene Therapy and Cytokine Immunotherapy

Siren Biotechnology announced the presentation of preclinical data demonstrating the effect of a novel treatment for cancer, Universal AAV Immuno-Gene Therapy, which combines AAV gene therapy and cytokine immunotherapy into a single modality.

May 17, 2023
·
4 min read
Mantra pharma maintains steady growth

Mantra Pharma maintains impressive growth completing 39 product launches, including all strengths, in the past 16 months.

May 17, 2023
·
1 min read
Opthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD Market

Opthea Limited announced that Elemer Piros, Senior Biotechnlogy Analyst at EF Hutton will host a webinar with Dr. Megan Baldwin, CEO and Managing Director and Timothy E. Morris, CFO of Opthea Limited on Thursday, May 18th at 5:00 pm EDT.

May 17, 2023
·
2 min read
Drug Development

Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023

Skyline Therapeutics, an innovation-driven gene therapy company dedicated to developing unique and novel solutions to address unmet needs in rare and severe diseases, is showcasing multiple data presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting.

May 17, 2023
·
2 min read
Genetown

KSQ Therapeutics and Takeda Expand Strategic Immuno-Oncology Collaboration to Identify and Validate Novel Tumor Targets

KSQ Therapeutics, a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics® discovery platform, announced that it has expanded its strategic collaboration with Takeda to research and validate novel tumor-intrinsic targets.

May 17, 2023
·
2 min read
Pharm Country

Henry Schein to Participate in Three Investor Conferences

Henry Schein, Inc. announced that the Company will present at the following investor conferences in May and June.

May 17, 2023
·
2 min read
Business

Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023

Kamada Ltd. today announced that it will release financial results for the first quarter ended March 31, 2023, prior to the open of the U.S. financial markets on Wednesday, May 24, 2023.

May 17, 2023
·
2 min read